Company: PHAT
Filing Date: 2025-05-13
Form Type: SCHEDULE 13D/A
Source: 0001415889-25-012779
Chunk: 3

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-05-13
Form: SCHEDULE 13D/A
Chunk 3
---
,270,327.00 |
| 11                                                                 |                                                                         7,270,327.00 |
| 12                                                                 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions) |
| 13                                                                 |                                                                               10.1 % |
| 14                                                                 |                                                                                   IN |

Comment for Type of Reporting Person: The shares listed in rows 8, 10 and 11 consist of (i) 3,963,667 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P., (ii) 1,774,790 shares of Common Stock issuable to Frazier Life Sciences Public Fund, L.P. pursuant to pre-funded warrants exercisable within 60 days of May 9, 2025, (iii) 1,008,323 shares of Common Stock held directly by Frazier Life Sciences Public Overage Fund, L.P. and (iv) 523,547 shares of Common Stock issuable to Frazier Life Sciences Public Overage Fund, L.P. pursuant to pre-funded warrants exercisable within 60 days of May 9, 2025. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P. FHMLSP Overage, L.P. is the general partner of Frazier Life Sciences Public Overage Fund, L.P. and FHMLSP Overage, L.L.C. is the general partner of FHMLSP Overage, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP Overage, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Overage Fund, L.P. The percentage listed in row 13 is calculated based the sum of (i) 69,814,121 shares of the Issuer's Common Stock outstanding as of April 29, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on May 1, 2025, (ii) 1,774,790